SG/PUT/AMGEN/300/0.1/21.06.24 | Delayed Deutsche Boerse AG 02:55:32 2024-06-14 am EDT | ||
| 0.37 EUR | 0.00% |
|
| Current month | -5.13% | ||
| 1 month | -21.28% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 0.37 | 0.00% |
| 24-06-13 | 0.37 | +12.12% |
| 24-06-12 | 0.33 | -2.94% |
| 24-06-11 | 0.34 | +41.67% |
| 24-06-10 | 0.24 | -7.69% |
Delayed Quote Deutsche Boerse AG
Last update June 14, 2024 at 02:55 am EDT
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SQ73LU |
| ISIN | DE000SQ73LU5 |
| Date issued | 2023-01-18 |
| Strike | 300 $ |
| Maturity | 2024-06-21 (8 Days) |
| Parity | 10 : 1 |
| Emission price | 4.16 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.08 € |
|---|---|
| Lowest since issue | 0.17 € |
| Spread | 0.1 € |
| Spread % | 21.28% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
298.5
USD
Average target price
316.3
USD
Spread / Average Target
+5.95%
- Stock Market
- Warrants
- Warrant
